Adicet Bio Inc (ACET)
2.10
+0.10
(+5.00%)
USD |
NASDAQ |
Apr 23, 16:00
2.08
-0.02
(-0.95%)
Pre-Market: 09:23
Adicet Bio Cash from Financing (TTM): 0.236M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.236M |
September 30, 2023 | 0.464M |
June 30, 2023 | 42.70M |
March 31, 2023 | 42.64M |
December 31, 2022 | 41.51M |
September 30, 2022 | 138.67M |
June 30, 2022 | 96.85M |
Date | Value |
---|---|
March 31, 2022 | 96.66M |
December 31, 2021 | 242.68M |
September 30, 2021 | 145.49M |
June 30, 2021 | 145.27M |
March 31, 2021 | 145.15M |
December 31, 2020 | 0.303M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.236M
Minimum
Dec 2023
242.68M
Maximum
Dec 2021
87.59M
Average
96.66M
Median
Mar 2022
Cash from Financing (TTM) Benchmarks
Sagimet Biosciences Inc | 86.17M |
Catalyst Pharmaceuticals Inc | -10.86M |
Codexis Inc | 8.167M |
Annexon Inc | 135.52M |
Inhibrx Inc | 201.96M |